Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition
Cancer of unknown primary (CUP) is a mysterious malignancy featuring metastatic dissemination in the absence of a recognizable primary tumor. By characterizing CUP cancer stem cells we show that self-sustained long-term propagation and sensitivity to MEK inhibition are CUP common features.
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-22643-w |
id |
doaj-4477922c33134d2989690669cbc5e8c0 |
---|---|
record_format |
Article |
spelling |
doaj-4477922c33134d2989690669cbc5e8c02021-05-09T11:12:13ZengNature Publishing GroupNature Communications2041-17232021-05-0112111610.1038/s41467-021-22643-wCancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibitionFederica Verginelli0Alberto Pisacane1Gennaro Gambardella2Antonio D’Ambrosio3Ermes Candiello4Marco Ferrio5Mara Panero6Laura Casorzo7Silvia Benvenuti8Eliano Cascardi9Rebecca Senetta10Elena Geuna11Andrea Ballabio12Filippo Montemurro13Anna Sapino14Paolo M. Comoglio15Carla Boccaccio16Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSTelethon Institute of Genetics and Medicine (TIGEM)Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCSLaboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCSLaboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSLaboratory of Exploratory Research and Molecular Cancer Therapy, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSMultidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCSTelethon Institute of Genetics and Medicine (TIGEM)Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCSUnit of Pathology, Candiolo Cancer Institute, FPO-IRCCSLaboratory of Exploratory Research and Molecular Cancer Therapy, Candiolo Cancer Institute, FPO-IRCCSLaboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCSCancer of unknown primary (CUP) is a mysterious malignancy featuring metastatic dissemination in the absence of a recognizable primary tumor. By characterizing CUP cancer stem cells we show that self-sustained long-term propagation and sensitivity to MEK inhibition are CUP common features.https://doi.org/10.1038/s41467-021-22643-w |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Federica Verginelli Alberto Pisacane Gennaro Gambardella Antonio D’Ambrosio Ermes Candiello Marco Ferrio Mara Panero Laura Casorzo Silvia Benvenuti Eliano Cascardi Rebecca Senetta Elena Geuna Andrea Ballabio Filippo Montemurro Anna Sapino Paolo M. Comoglio Carla Boccaccio |
spellingShingle |
Federica Verginelli Alberto Pisacane Gennaro Gambardella Antonio D’Ambrosio Ermes Candiello Marco Ferrio Mara Panero Laura Casorzo Silvia Benvenuti Eliano Cascardi Rebecca Senetta Elena Geuna Andrea Ballabio Filippo Montemurro Anna Sapino Paolo M. Comoglio Carla Boccaccio Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition Nature Communications |
author_facet |
Federica Verginelli Alberto Pisacane Gennaro Gambardella Antonio D’Ambrosio Ermes Candiello Marco Ferrio Mara Panero Laura Casorzo Silvia Benvenuti Eliano Cascardi Rebecca Senetta Elena Geuna Andrea Ballabio Filippo Montemurro Anna Sapino Paolo M. Comoglio Carla Boccaccio |
author_sort |
Federica Verginelli |
title |
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition |
title_short |
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition |
title_full |
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition |
title_fullStr |
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition |
title_full_unstemmed |
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition |
title_sort |
cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to mek inhibition |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2021-05-01 |
description |
Cancer of unknown primary (CUP) is a mysterious malignancy featuring metastatic dissemination in the absence of a recognizable primary tumor. By characterizing CUP cancer stem cells we show that self-sustained long-term propagation and sensitivity to MEK inhibition are CUP common features. |
url |
https://doi.org/10.1038/s41467-021-22643-w |
work_keys_str_mv |
AT federicaverginelli cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT albertopisacane cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT gennarogambardella cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT antoniodambrosio cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT ermescandiello cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT marcoferrio cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT marapanero cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT lauracasorzo cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT silviabenvenuti cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT elianocascardi cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT rebeccasenetta cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT elenageuna cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT andreaballabio cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT filippomontemurro cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT annasapino cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT paolomcomoglio cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition AT carlaboccaccio cancerofunknownprimarystemlikecellsmodelmultiorganmetastasisandunveilliabilitytomekinhibition |
_version_ |
1721454587648409600 |